Where to Start

Kyriakis, J. M. 2014. In the beginning, there was protein phosphorylation. J. Biol. Chem. 289:9460—9462.

Changeux, J.-P. 2011. 50th anniversary of the word ‘‘Allosteric.” Protein Sci. 20:1119–1124.

Kantrowitz, E. R., and Lipscomb, W. N. 1990. Escherichia coli aspartate transcarbamoylase: The molecular basis for a concerted allosteric transition. Trends Biochem. Sci. 15:53–59.

Schachman, H. K. 1988. Can a simple model account for the allosteric transition of aspartate transcarbamoylase? J. Biol. Chem. 263:18583–18586.

Neurath, H. 1989. Proteolytic processing and physiological regulation. Trends Biochem. Sci. 14:268–271.

Bode, W., and Huber, R. 1992. Natural protein proteinase inhibitors and their interaction with proteinases. Eur. J. Biochem. 204: 433–451.

Changeux, J.-P. 2012. Allostery and the Monod-Wyman-Changeux Model After 50 Years. Annu. Rev. Biophys. 41:103–133.

Peterson, A. W., Cockrell, G. M., and Kantrowitz, E. R. 2012. A second allosteric site in Escherichia coli aspartate transcarbamoylase. Biochemistry 51:4776−4778.

Rabinowitz, J. D., Hsiao, J. J., Gryncel, K. R., Kantrowitz, E. R., Feng, X.-J., Li, G., and Rabitz H. 2008. Dissecting enzyme regulation by multiple allosteric effectors: Nucleotide regulation of aspartate transcarbamoylase. Biochemistry 47:5881–5888.

West, J. M., Tsuruta, H., and Kantrowitz, E. R. 2004. A fluorescent probe-labeled Escherichia coli aspartate transcarbamoylase that monitors the allosteric conformation state. J. Biol. Chem. 279:945–951.

Endrizzi, J. A., Beernink, P. T., Alber, T., and Schachman, H. K. 2000. Binding of bisubstrate analog promotes large structural changes in the unregulated catalytic trimer of aspartate transcarbamoylase: Implications for allosteric regulation. Proc. Natl. Acad. Sci. U.S.A. 97:5077–5082.

Beernink, P. T., Endrizzi, J. A., Alber, T., and Schachman, H. K. 1999. Assessment of the allosteric mechanism of aspartate transcarbamoylase based on the crystalline structure of the unregulated catalytic subunit. Proc. Natl. Acad. Sci. U.S.A. 96:5388–5393.

Wales, M. E., Madison, L. L., Glaser, S. S., and Wild, J. R. 1999. Divergent allosteric patterns verify the regulatory paradigm for aspartate transcarbamoylase. J. Mol. Biol. 294:1387–1400.

Newell, J. O., Markby, D. W., and Schachman, H. K. 1989. Cooperative binding of the bisubstrate analog N-(phosphonacetyl)-L-aspartate to aspartate transcarbamoylase and the heterotropic effects of ATP and CTP. J. Biol. Chem. 264:2476–2481.

Stevens, R. C., Gouaux, J. E., and Lipscomb, W. N. 1990. Structural consequences of effector binding to the T state of aspartate carbamoyl-transferase: Crystal structures of the unligated and ATP- and CTP-complexed enzymes at 2.6-Å resolution. Biochemistry 29:7691–7701.

Gouaux, J. E., and Lipscomb, W. N. 1990. Crystal structures of phosphonoacetamide ligated T and phosphonoacetamide and malonate ligated R states of aspartate carbamoyltransferase at 2.8-Å resolution and neutral pH. Biochemistry 29:389–402.

Labedan, B., Boyen, A., Baetens, M., Charlier, D., Chen, P., Cunin, R., Durbeco, V., Glansdorff, N., Herve, G., Legrain, C., et al. 1999. The evolutionary history of carbamoyltransferases: A complex set of paralogous genes was already present in the last universal common ancestor. J. Mol. Evol. 49:461–473.

Endicott, J. A., Noble, M. E. M., and Johnson, L. N. 2012. The structural basis for control of eukaryotic protein kinases. Annu. Rev. Biochem. 81:587–613.

Tarrant, M. K., and Cole, P. A. 2009. The chemical biology of protein phosphorylation Annu. Rev. Biochem. 78:797–825.

Guarente, L. 2011. The logic linking protein acetylation and metabolism. Cell Metab. 14:151–153.

Guan, K-L., and Xiong, Y. 2011. Regulation of intermediary metabolism by protein acetylation. Trends Biochem. Sci. 36:108–116.

Johnson, L. N., and Barford, D. 1993. The effects of phosphorylation on the structure and function of proteins. Annu. Rev. Biophys. Biomol. Struct. 22:199–232.

Barford, D., Das, A. K., and Egloff, M. P. 1998. The structure and mechanism of protein phosphatases: Insights into catalysis and regulation. Annu. Rev. Biophys. Biomol. Struct. 27:133–164.

Taylor, S. S., Ilouz, R., Zhang, P., and Kornev, A. P. 2012. Assembly of allosteric macromolecular switches: Lessons from PKA. Nature Rev. Mol. Cell Biol. 13:646–658.

Zhang, P., Smith-Nguyen, E. V., Keshwani, M. M., Deal, M. S., Kornev, A. P., and Taylor, S. S. 2012. Structure and allostery of the PKA RIIb tetrameric holoenzyme. Science 334:712–716.

Taylor, S. S., and Kornev, A. P. 2011. Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem. Sci. 36:65–77.

Pearlman, S. M., Serber, Z., and Ferrell Jr., J. E. 2011. A mechanism for the evolution of phosphorylation sites. Cell 147:934–946.

Knighton, D. R., Zheng, J. H., TenEyck, L., Xuong, N. H., Taylor, S. S., and Sowadski, J. M. 1991. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253:414–420.

Artenstein, A. W., and Opal, S. M. 2011. Proprotein convertases in health and disease. New Engl. J. Med. 65:2507–2518.

Neurath, H. 1986. The versatility of proteolytic enzymes. J. Cell. Biochem. 32:35–49.

Bode, W., and Huber, R. 1986. Crystal structure of pancreatic serine endopeptidases. In Molecular and Cellular Basis of Digestion (pp. 213–234), edited by P. Desnuelle, H. Sjostrom, and O. Noren. Elsevier.

James, M. N. 1991. Refined structure of porcine pepsinogen at 1.8 Å resolution. J. Mol. Biol. 219:671–692.

Gooptu, B., and Lomas, D. A. 2009. Conformational Pathology of the Serpins: Themes, Variations, and Therapeutic Strategies. Annu. Rev. Biochem. 78:147–167.

Carrell, R., and Travis, J. 1985. α₁-Antitrypsin and the serpins: Variation and countervariation. Trends Biochem. Sci. 10:20–24.

Carp, H., Miller, F., Hoidal, J. R., and Janoff, A. 1982. Potential mechanism of emphysema: α₁-Proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc. Natl. Acad. Sci. U.S.A. 79:2041–2045.

B10

Owen, M. C., Brennan, S. O., Lewis, J. H., and Carrell, R. W. 1983. Mutation of antitrypsin to antithrombin. New Engl. J. Med. 309: 694–698.

Travis, J., and Salvesen, G. S. 1983. Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52:655–709.

Kollman, J. M., Pandi, L., Sawaya, M. R., Riley, M., and Doolittle, R. F. 2009. Crystal structure of human fibrinogen. Biochemistry 48: 3877–3886.

Furie, B., and Furie, B. C. 2008. Mechanisms of thrombus formation. New Engl. J. Med. 359:938–949.

Orfeo, T., Brufatto, N., Nesheim, M. E., Xu, H., Butenas, S., and Mann, K. G. 2004. The factor V activation paradox. J. Biol. Chem. 279:19580–19591.

Mann, K. G. 2003. Thrombin formation. Chest 124:4S–10S.

Rose, T., and Di Cera, E. 2002. Three-dimensional modeling of thrombin–-fibrinogen interaction. J. Biol. Chem. 277:18875–18880.

Krem, M. M., and Di Cera, E. 2002. Evolution of cascades from embryonic development to blood coagulation. Trends Biochem. Sci. 27:67–74.

Fuentes-Prior, P., Iwanaga, Y., Huber, R., Pagila, R., Rumennik, G., Seto, M., Morser, J., Light, D. R., and Bode, W. 2000. Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex. Nature 404:518–525.

Lawn, R. M., and Vehar, G. A. 1986. The molecular genetics of hemophilia. Sci. Am. 254(3):48–65.